Featured
Read our handpicked blogs, curated for you.
|
The risk landscape for global finance has moved beyond simple predictive modeling. For years, AI for risk management in…
|
The landscape of financial crime has entered a new era of technical sophistication. For years, AI for fraud detection…
|
The Evolution of Banking Data QualityThe first generation of banking data quality tools relied on rigid, rules-based…
Recent releases
|
The cost of slow content in pharma marketing and how to amplify it
Every pharma marketer knows the story. A campaign is planned around a new therapy, the slides are drafted, medical-legal-regulatory begins its review, weeks pass, edits keep coming back, and by the…
|
UCPMP 2024 changes pharma marketers must act on
For years, pharma marketing in India carried a reputation for being stuck between outdated field-force practices and patchy digital adoption. That space has shifted. UCPMP 2024 is not just an update…
|
AI-Powered Pharma Market Access: Tier 2 and Tier 3 Strategy
Pharma market access in India has shifted. Growth in metros is plateauing, competition is fierce, and doctors in top cities are over-engaged. The next wave lies in Tier 2 and Tier 3 India, where…
|
Gamification in Pharma Marketing: Boosting HCP and Patients
Pharma marketing has reached a turning point. Doctors are overwhelmed with information. Patients are distracted, skeptical, and inconsistent in following therapies. Regulators keep tightening the…
